Clik here to view.
Biodesix® and Bioyong Announce Agreement for Joint Development and...
BOULDER, Colo. Biodesix, Inc. and Bioyong Technology Company Ltd. (Beijing, China) announced today that they have entered into an international collaboration agreement where Bioyong will develop and...
View ArticleClik here to view.
Kite Pharma Establishes a Strategic Partnership With Daiichi Sankyo to...
SANTA MONICA, Calif. Kite Pharma (Nasdaq:KITE) announced today that it has entered into a strategic partnership with Daiichi Sankyo Co., Ltd. (Daiichi Sankyo) for axicabtagene ciloleucel (approved...
View ArticleClik here to view.
First Pulmonary Embolism Patients in Hong Kong Treated with the EKOS® system
LONDON BTG plc (LSE: BTG), the global specialist healthcare company, today announced the first patients diagnosed with Pulmonary Embolism (PE) to be treated in Hong Kong using the newly available...
View ArticleClik here to view.
Director YimJoongHyuk of TL Plastic Surgery Korea: Satisfactory Breast...
SEOUL, South Korea Increasing number of people are starting to pay attention to their body shape. Efforts like diet and exercise can help improve their figure to some extent but have little effect...
View ArticleClik here to view.
Kite Pharma and Fosun Pharma Establish Joint Venture in China to Develop and...
SANTA MONICA, Calif. & SHANGHAI Kite Pharma (Nasdaq:KITE) and Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (Fosun Pharma) (600196.SH,02196.HK), today announced a joint venture, Fosun Pharma...
View ArticleClik here to view.
LFB S.A.、血液凝固第VIIa因子組み換え製剤（活性型エプタコグベータ）に関し提出済みの生物学的製剤承認申請を米食品医薬品局（FDA）が受理したと本日発表
仏レジュリス （ビジネスワイヤ） — LFB...
View ArticleClik here to view.
POC Medical Systems™ Raises $21 Million in Series A Funding to Advance Rapid,...
LIVERMORE, Calif. POC Medical Systems™ Inc. announced today that it raised $ 21 million in Series A funding for clinical beta testing and initial commercialization of a rapid, portable breast cancer...
View ArticleClik here to view.
Maverick Therapeutics and Takeda Announce Five-year Collaboration to Advance...
BRISBANE, Calif. & CAMBRIDGE, Mass. & OSAKA, Japan Maverick Therapeutics Inc., an MPM Capital portfolio company, and Takeda Pharmaceutical Company Limited (TSE:4502) announced today that...
View ArticleClik here to view.
Orthocell Announces Collaboration with Johnson & Johnson Innovation
PERTH, Australia Regenerative medicine company Orthocell Limited has today announced a research collaboration agreement with DePuy Synthes Products, Inc., part of the Johnson & Johnson Family of...
View ArticleClik here to view.
Tocagen Expands Toca 5, Phase 2/3 Clinical Trial for Recurrent Brain Cancer,...
SAN DIEGO Tocagen Inc., a clinical-stage, cancer-selective gene therapy company, today announced its randomized, controlled Phase 2/3 clinical trial, called Toca 5, is now enrolling patients in...
View ArticleClik here to view.
Chi-Med Initiates a Phase II Combination Study of Fruquintinib with Iressa®...
LONDON Hutchison China MediTech Limited (“Chi-Med”) (AIM/Nasdaq: HCM) today announces that it has initiated a Phase II study of a combination therapy using fruquintinib and Iressa® in the first-line...
View ArticleClik here to view.
nano tech 2017, the International Nanotechnology Exhibition & Conference,...
TOKYO The nano tech executive committee (chairman: Tomoji Kawai, Specially Appointed Professor, Osaka University) will be holding “nano tech 2017” – one of the world’s largest nanotechnology...
View ArticleClik here to view.
“nano tech 2017 国際ナノテクノロジー総合展・技術会議”開催、超スマート社会の実現に貢献する最先端技術・材料の最新情報を発信！
東京 （ビジネスワイヤ） — nano tech 実行委員会（委員長：大阪大学 川合 知二 教授）は、来る2017 年2 月15 日～17 日の3 日間、東京ビッグサイトにて、世界最大級のナノテクノロジーの展示会、nano tech 2017 第16 回国際ナノテクノロジー総合展・技術会議を開催します。40 社以上の新規出展を含む600 社(1,000 小間 / 23...
View ArticleClik here to view.
国际纳米技术展览暨研讨会——2017纳米科技展将为您带来尖端技术与材料的最新资讯，令超智能社会触手可及
东京 (美国商业资讯)–日本纳米技术委员会（主席：日本大阪大学特聘教授Tomoji Kawai）将于2017年2月15日在东京都有明国际展览中心(Tokyo Big Sight)举办全球最大的纳米科技展之一——2017纳米科技展(nano tech...
View ArticleClik here to view.
Takeda Commences Cash Tender Offer for All Outstanding Shares of ARIAD...
OSAKA, Japan & CAMBRIDGE, Mass. Takeda Pharmaceutical Company Limited (TOKYO:4502) (“Takeda”) today announced the commencement of the cash tender offer by its wholly-owned indirect subsidiary,...
View ArticleClik here to view.
武田薬品: ARIAD社の発行済み全株式に対する現金による公開買付けの開始について
大阪 & 米マサチューセッツ州ケンブリッジ （ビジネスワイヤ） – 当社は、米国時間の2017年1月19日、ARIAD Pharmaceuticals, Inc.（本社：マサチューセッツ州ケンブリッジ、以下「ARIAD社」）の発行済み全株式に対し、当社の間接的な100％子会社であるKiku Merger Co.,...
View ArticleClik here to view.
InFo 124M – 瑞士生产的用于白内障手术的延伸焦深人工晶体
瑞士纳沙泰尔 (美国商业资讯) — Swiss Advanced Vision公司(SAV-IOL SA – www.sav-iol.com)不断壮大其人工晶体(IOL)产品阵容，宣布上市一款新产品，该产品基于该公司于2016年1月首次上市的InFo系列。InFo晶体旨在白内障手术后替换晶状体，使患者恢复视力，免于佩戴眼镜，避免了不必要的视觉不良效应，并保全解像度。 Smart News...
View ArticleClik here to view.
ファインデックス、愛媛大工学部・京都大医学部との共同研究により新たな検査手法を用いた視野検査システムの開発に着手
東京 （ビジネスワイヤ） — 株式会社ファインデックス（東証一部：3649 本社：東京 代表取締役：相原輝夫、以下ファインデックス）は、国立大学法人愛媛大学（学長：大橋 裕一、以下愛媛大学）と「新規視覚特性計測法を用いた視野計測装置の研究開発」、および国立大学法人京都大学（総長：山極 壽一、以下京都大学）との「視機能評価プログラム医療機器開発研究」に着手いたしました。...
View ArticleClik here to view.
武田药品工业株式会社开始对ARIAD Pharmaceuticals, Inc.所有流通股进行现金要约收购
日本大阪与马萨诸塞州剑桥 (美国商业资讯)–武田药品工业株式会社(Takeda Pharmaceutical Company Limited)(TOKYO:4502)（简称“武田”）今日宣布，公司通过其间接全资子公司，开始对ARIAD Pharmaceuticals, Inc. (NASDAQ:ARIA)...
View ArticleClik here to view.
InFo 124M – スイス製の白内障手術用EDOF IOL
スイス・ヌーシャテル （ビジネスワイヤ） — Swiss Advanced Vision（SAV-IOL SA –...
View Article